These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23806452)

  • 21. Mast cell activation syndromes: definition and classification.
    Valent P
    Allergy; 2013 Apr; 68(4):417-24. PubMed ID: 23409940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
    Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
    N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical spectrum of mastocytosis].
    Langer K; Wolff K
    Hautarzt; 1990 Apr; 41(4):188-95. PubMed ID: 2192996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic mastocytosis. A little-known disease].
    Carrillo Muñoz R; Blanco Blanco A; Alegre Martín J; Capdevila Morell JA; Fernández de Sevilla T; Martínez Vázquez JM
    An Med Interna; 1993 Mar; 10(3):138-42. PubMed ID: 8485285
    [No Abstract]   [Full Text] [Related]  

  • 26. Mastocytosis.
    Metcalfe DD
    Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Management of a Patient With Possible Mast Cell Activation Syndrome Undergoing Pulmonary Embolectomy: A Case Report.
    Richter EW; Hsu KL; Moll V
    A A Case Rep; 2017 May; 8(9):232-234. PubMed ID: 28181942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital].
    Hägglund H; Gülen T; Sääf M; Sander B; Nilsson G
    Lakartidningen; 2008 Nov 12-18; 105(46):3341-4, 3346-7. PubMed ID: 19062626
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mastocytosis--a review illustrated by two case reports].
    Dalgaard J; Ritland S; Brinch L; Ikonomou IM
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1312-5. PubMed ID: 10868093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved metastatic uterine papillary serous cancer outcome with treatment of mast cell activation syndrome.
    Afrin LB; Spruill LS; Schabel SI; Young-Pierce JL
    Oncology (Williston Park); 2014 Feb; 28(2):129-31, 134. PubMed ID: 24701700
    [No Abstract]   [Full Text] [Related]  

  • 32. [NON-CLONAL MAST CELL ACTIVATION SYNDROME: DESCRIPTION OF SERIES OF PATIENTS, DIAGNOSTIC CRITERIA AND TREATMENT].
    Confino-Cohen R; Mekori YA
    Harefuah; 2015 Aug; 154(8):507-9, 540. PubMed ID: 26480615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cutaneosystemic congenital mastocytosis].
    Labeille B; Kremp O; Lok C; Teillac D; Risbourg B; Denoeux JP; de Prost Y
    Ann Dermatol Venereol; 1990; 117(11):805-6. PubMed ID: 2099685
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mastocytic enterocolitis: a newly described mast cell entity.
    Ogilvie-McDaniel C; Blaiss M; Osborn FD; Carpenter J
    Ann Allergy Asthma Immunol; 2008 Dec; 101(6):645-6. PubMed ID: 19119712
    [No Abstract]   [Full Text] [Related]  

  • 36. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification and response criteria in mast cell disorders: time to revise?
    Valent P; Horny HP
    Int Arch Allergy Immunol; 2011; 155(3):306-8. PubMed ID: 21293151
    [No Abstract]   [Full Text] [Related]  

  • 38. [Systemic mastocytosis].
    Sade K; Dotan I; Levo Y
    Harefuah; 2000 Sep; 139(5-6):202-6, 245. PubMed ID: 11062953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaesthesia in patients with mastocytosis.
    Konrad FM; Schroeder TH
    Acta Anaesthesiol Scand; 2009 Feb; 53(2):270-1. PubMed ID: 19175585
    [No Abstract]   [Full Text] [Related]  

  • 40. Which opioids in case of mast cell activation disorders?
    Lepelley M; Khouri C; Pralong P; Rossignol J; Greco C; Bouillet L; Gibod IB
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1317-1318. PubMed ID: 30172016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.